The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 02, 2026 for Ravi Agrawal, trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Promoter Ravi Agrawal, through the Ravi Agrawal Trust, has disclosed both a release and a fresh creation of pledge on Ajanta Pharma shares under SEBI SAST Regulations. He released pledges on 2,60,000 equity shares — 1,60,000 with Aditya Birla Capital and 1,00,000 with Bajaj Finance — citing 'Excess Pledge' as the reason. Simultaneously, he created a fresh pledge of 2,20,000 shares with The South Indian Bank Ltd for re-financing purposes. On a net basis, pledged shares reduced by 40,000, taking post-event encumbered holding to 60,23,920 shares (4.82% of total share capital) against a promoter holding of 1,62,42,904 shares (13.00%).
This is routine re-financing activity by the promoter — shares have not been sold, and overall promoter pledge burden has only marginally declined. No material impact expected on stock price; reassures investors that the promoter is actively managing debt rather than facing stress.